Humalog Mix50 100U/mL Injection is a premixed insulin containing Insulin Lispro 50% (rapid-acting) and Insulin Lispro Protamine 50% (intermediate-acting), designed to manage blood glucose levels in diabetic patients. Manufactured by Eli Lilly, it provides quick mealtime glucose control along with longer basal coverage, suitable for both Type 1 and Type 2 diabetes. Its export-quality stability makes it viable for international demand.

Side Effects: May include hypoglycemia (low blood sugar), mild weight gain, injection-site redness or swelling, itching, changes in potassium levels, and rare allergic reactions.